MLAB

$81.69

Post-MarketAs of Mar 17, 8:00 PM UTC

Mesa Laboratories, Inc.

Recent News

Insider Monkey
Feb 20, 2026

Here’s Why Conestoga Capital Advisors Sold Mesa Laboratories (MLAB)

Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2025 investor letter. As many believe, US equities experienced solid returns in 2025, with double-digit gains across all major indices, yet underlying conditions revealed extreme volatility and market leadership. A copy of the letter can be downloaded here. In Q4 2025, Conestoga Capital Advisors Small Cap Strategy […]

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Feb 5, 2026

Mesa Laboratories, Inc.'s (NASDAQ:MLAB) Stock Going Strong But Fundamentals Look Weak: What Implications Could This Have On The Stock?

Most readers would already be aware that Mesa Laboratories' (NASDAQ:MLAB) stock increased significantly by 22% over the...

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
Associated Press Finance
Feb 3, 2026

Mesa Labs: Fiscal Q3 Earnings Snapshot

LAKEWOOD, Colo. AP) — Mesa Laboratories Inc. MLAB) on Tuesday reported earnings of $3.6 million in its fiscal third quarter.

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
Simply Wall St.
Jan 11, 2026

Mesa Laboratories' (NASDAQ:MLAB) Dividend Will Be $0.16

The board of Mesa Laboratories, Inc. ( NASDAQ:MLAB ) has announced that it will pay a dividend of $0.16 per share on...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Dec 7, 2025

Should You Investigate Mesa Laboratories, Inc. (NASDAQ:MLAB) At US$77.63?

Mesa Laboratories, Inc. ( NASDAQ:MLAB ), might not be a large cap stock, but it saw a significant share price rise of...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.